Page last updated: 2024-08-22

azetidyl-2-carboxylic acid and Diabetes Mellitus

azetidyl-2-carboxylic acid has been researched along with Diabetes Mellitus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoue, H; Nakamura, K; Yamagishi, S	1

Other Studies

1 other study(ies) available for azetidyl-2-carboxylic acid and Diabetes Mellitus

Article	Year
Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist. Medical hypotheses, 2005, Volume: 65, Issue:1 Topics: Antihypertensive Agents; Antioxidants; Arteriosclerosis; Azetidinecarboxylic Acid; Biomarkers; Calcium; Cardiovascular Diseases; Cells, Cultured; Chemokine CCL2; Diabetes Mellitus; Dihydropyridines; Endothelium, Vascular; Humans; Hypertension; Insulin Resistance; Interleukin-8; Models, Biological; Reactive Oxygen Species; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; Umbilical Veins	2005

Article

Year

Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist.

Medical hypotheses, 2005, Volume: 65, Issue:1

Topics: Antihypertensive Agents; Antioxidants; Arteriosclerosis; Azetidinecarboxylic Acid; Biomarkers; Calcium; Cardiovascular Diseases; Cells, Cultured; Chemokine CCL2; Diabetes Mellitus; Dihydropyridines; Endothelium, Vascular; Humans; Hypertension; Insulin Resistance; Interleukin-8; Models, Biological; Reactive Oxygen Species; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; Umbilical Veins

2005